New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx ...
Proponents of IV therapy say it can cure fibromyalgia, chronic fatigue, chronic pain, and even the cold and flu. Read more about this alternative treatment.
Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of ...
Successful management of denture-associated candidiasis relies heavily on mechanical disinfection rather than pharmacologic ...
Many adults, perhaps including you, wake up feeling tired and become easily overwhelmed by everyday pressures. The post How ...
The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...
MoU enables 24/7 access to doctors, nurses, emergency services, and preventive healthcare at the campus wellness center.,, ...
An oncology pharmacist shares how a treatment takes a different approach to treating chronic graft-versus-host disease (GVHD) ...
Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation AwardExpands iNKT platform into ...
When a person suffers a stroke, physicians must restore blood flow to the brain as quickly as possible to save their life.
NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...
As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate pelacarsen to a Phase III test of Eli Lilly’s next-gen Alzheimer's drug—are poised ...